Marks I N, Wright J P, Lucke W, Girdwood A H
Scand J Gastroenterol. 1982 Apr;17(3):429-32. doi: 10.3109/00365528209182081.
The relapse rate after successful short-term therapy with sucralfate (Sc) or cimetidine (Cm) was studied in a group of 86 patients with recently healed duodenal or gastric ulcers. The patients were endoscoped on clinical relapse or, routinely, at 6 weeks, 6 months, and 1 year. Patients whose ulcers had healed with Cm relapsed earlier than did those whose ulcers had healed with Sc (p less than 0.05 at 12 weeks), but the cumulative relapse rate by the end of 1 year was of the order of 70% in both treatment groups. The mean duration of remission in patients who developed a recurrence was significantly greater in patients treated initially with Sc than in those treated initially with Cm--7.3 and 4.6 months, respectively (p less than 0.01).
对一组86例近期愈合的十二指肠溃疡或胃溃疡患者进行了研究,观察了用硫糖铝(Sc)或西咪替丁(Cm)进行成功短期治疗后的复发率。在临床复发时或常规在6周、6个月和1年时对患者进行内镜检查。用Cm治愈溃疡的患者比用Sc治愈溃疡的患者复发更早(12周时p<0.05),但两个治疗组到1年末的累积复发率均约为70%。复发患者的平均缓解期,初始用Sc治疗的患者明显长于初始用Cm治疗的患者,分别为7.3个月和4.6个月(p<0.01)。